Schizoaffective Disorders Completed Phase 4 Trials for Raloxifene (DB00481)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00361543Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of SchizophreniaTreatment